ATP Cancer Research Results

ATP, Adenosine triphosphate: Click to Expand ⟱
Source:
Type:
Adenosine triphosphate (ATP) is the source of energy for use and storage at the cellular level.
Cellular ATP levels are critical for cell survival, and several reports have shown that reductions in cellular ATP levels can lead to apoptosis and other types of cell death in cancer cells, depending on the level of depletion.
Adenosine triphosphate (ATP) is one of the main biochemical components of the tumor microenvironment (TME), where it can promote tumor progression or tumor suppression depending on its concentration and on the specific ecto-nucleotidases and receptors expressed by immune and cancer cells.

Cancer cells, unlike normal cells, derive as much as 60% of their ATP from glycolysis via the “Warburg effect”, and the remaining 40% is derived from mitochondrial oxidative phosphorylation.


Scientific Papers found: Click to Expand⟱
6815- EMD,    NMR-based Metabolomic Techniques Identify the Toxicity of Emodin in HepG2 Cells
- in-vitro, Liver, HepG2
AntiCan↑, *hepatoP↑, *Inflam↓, *antiOx↑, *AntiBio↑, *toxicity↝, tumCV↓, TumCP↓, Apoptosis↑, ALAT↓, glucose↓, GSH↓, ATP↓,
1322- EMD,    The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers
- Review, Var, NA
Apoptosis↑, TumCP↓, ROS↑, TumAuto↑, EMT↓, TGF-β↓, DNAdam↑, ER Stress↑, TumCCA↑, ATP↓, NF-kB↓, CYP1A1↑, STAC2↓, JAK↓, PI3K↓, Akt↓, MAPK↓, FASN↓, HER2/EBBR2↓, ChemoSen↑, Synergy↑, ChemoSen↑, angioG↓, VEGF↓, MMP2↓, eNOS↓, FOXD3↑, MMP9↓, TIMP1↑,
5495- EP,    Irreversible electroporation in focal therapy for prostate cancer: current status and future directions
- Review, Pca, NA
Ca+2↑, ATP↓, mtDam↑, ROS↑, CellMemb↑,
4251- FA,    Antidepressant-Like Effect of Ferulic Acid via Promotion of Energy Metabolism Activity
- in-vivo, AD, NA
*BDNF↑, *ATP↑, *Mood↑,
6981- Form,    Formononetin: a review of its source, pharmacology, drug combination, toxicity, derivatives, and drug delivery systems
- Review, Var, NA - Review, AD, NA - Review, PSA, NA
BioAv↝, *memory↑, *ROS↓, *AChE↓, *NF-kB↓, *Keap1↝, *NRF2↑, *Inflam↓, *PGC-1α↝, *HO-1↓, *p‑tau↓, *cognitive↑, *BDNF↑, *5HT↑, *Stroke↓, *PARP1↓, *AIF↓, *Casp3↓, NP/CIPN↓, *neuroP↑, *NGF↑, *TNF-α↓, *IL1β↓, *IL18↓, *IL6↓, *VCAM-1↓, *pol-M2 MC↑, *hepatoP↑, *AST↓, *ALAT↓, *LC3II↑, *Beclin-1/ATG6↑, *p62↑, *COX2/PTGS2↑, *MMP↑, *ATP↑, *GSH↑, *Catalase↑, *GPx↑, *MDA↓, *antiPs↑, *AntiDiabetic↑, *glucose↓, *Insulin↑, *GutMicro↑, *Obesity↓, COX2/PTGS2↓, cycD1/CCND1↓, TumCCA↑, EGFR↓, GSK‐3β↑, Mcl-1↓, *toxicity↓, TumCP↓, Hif1a↓, VEGF↓, ERK↓, LAMs↓, Cyt‑c↑, Casp9↑, Casp3↑, PARP↑, TumCD↑, mitA↑, BACH1↓, P53↓, ROS↑, PD-1↓, NF-kB↓, *Bacteria↓, *AntiViral↑, *mt-ROS?, *PI3K↓, *chemoP↑, ChemoSen↑, Synergy↑, *toxicity↓, *BioAv↑, *BioAv↑, *Synergy↑, *antiAll↑,
6971- Form,    In vitro and in vivo anti-cancer activity of formononetin on human cervical cancer cell line HeLa
- vitro+vivo, Cerv, HeLa
p‑Akt↓, Apoptosis↑, TumCG↓, Dose↝, PI3K↓, eff↑, ATP↓, OCR↓, TumCCA↑, IGF-1↓, angioG↓, TumCI↓,
5205- Gallo,    Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells
- in-vitro, Endo, ISH
LDH↓, TumCG↓, LDHA↓, Apoptosis↑, cl‑Casp3↑, Mcl-1↓, Bcl-2↓, TumCCA↑, ROS↑, mt-DNAdam↑, GlucoseCon↓, ATP↓, PDH↑, Pyruv↑, Glycolysis↓, TCA↑, cMyc↓, E-cadherin↑, Slug↓,
935- Gallo,    Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways
- in-vitro, BC, MCF7 - in-vitro, BC, MDA-MB-231
LDH↓, ROS↑, TumCP↓, Glycolysis↓, ATP↓, ER-α36↓, Apoptosis?,
7195- GBE,    Mitochondrial effects of Ginkgo biloba extract
- Review, AD, NA
*ROS↓, *mitResp↑, *AntiAge↑, *ATP↑, *neuroP↑, *ETC↑, *compI↑,
7212- GBE,    The Use of Ginkgo Biloba L. as a Neuroprotective Agent in the Alzheimer’s Disease
- Review, AD, NA
*antiOx↑, *ROS↓, *mitResp↑, *Casp9↓, *Casp3↓, *Apoptosis↓, *ATP↑, *neuroP↑, *IL1β↓, *IL6↓, *TNF-α↓, *PGE2↓, *memory↑, *cognitive↑, *BloodF↑, *lipid-P↓, *Aβ↓, *MAOA↓, *DA↑, *Dose↝, *toxicity↓,
7282- Gins,    Ginsenoside Rh2 stimulates the production of mitochondrial reactive oxygen species and induces apoptosis of cervical cancer cells by inhibiting mitochondrial electron transfer chain complex
- in-vitro, Cerv, NA
compI↓, compIII↓, ETC↓, ROS↑, Apoptosis↑, tumCV↓, selectivity↑, MMP↓, ATP↓, OXPHOS↓, ECAR↓, Glycolysis↓,
7321- Gos,    The potential roles of gossypol as anticancer agent: advances and future directions
- Review, Var, NA
other↝, BioAv↑, Bcl-2↓, Casp3↑, Casp9↑, MOMP↑, ROS↑, ATP↓, mtDam↑, Apoptosis↑, hTERT/TERT↓, Akt↓, TumAuto↑, LC3‑Ⅱ/LC3‑Ⅰ↑, NRF2↓, ARE↓, ICAM-1↓, CX43/GJA1↓, NF-kB↓, TLR4↓, IL6↓, Inflam↓, CUL5↝, CUL1↝, NOXA↑, TumCI↓, TumCMig↓, TumCA↓, FAK↓, MDM2↓, VEGF↓, angioG↓, HLA-I/II↑, Imm↑, Dose↝, Glycolysis↓, OXPHOS↓,
7310- Gos,    Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells
- in-vitro, AML, NA
TumCD↑, MOMP↑, ROS↑, ATP↓, BAX↑, Cyt‑c↑, AIF↑,
7335- Gra,    Effect of Annona muricata (Soursop) on Patients with Cancer: A Systematic Review
- Review, Var, NA
TumCG↓, Casp↑, Inflam↓, toxicity↓, other↑, TumCCA↑, Apoptosis↑, TumAuto↑, ATP↓, AIF↑, MMP↓, MOMP↑, Cyt‑c↑, selectivity↑, hepatoP∅,
845- Gra,    A Review on Annona muricata and Its Anticancer Activity
- Review, Var, NA
GlucoseCon↓, ATP↓, HIF-1↓, GLUT1↓, GLUT4↓, HK2↓, LDHA↓, ERK↓, Akt↓, Apoptosis↑, NF-kB↓, ROS↑, Bax:Bcl2↑, MMP↓, Casp3↑, Casp9↑, p‑JNK↓,
840- Gra,    Evaluation of cytotoxicity of aqueous extract of Graviola leaves on squamous cell carcinoma cell-25 cell lines by 3-(4,5-dimethylthiazol-2-Yl) -2,5-diphenyltetrazolium bromide assay and determination of percentage of cell inhibition at G2M phase of cell cycle by flow cytometry: An in vitro study
- in-vitro, SCC, SCC25
TumCCA↑, ATP↓,
836- Gra,    Graviola: A Novel Promising Natural-Derived Drug That Inhibits Tumorigenicity and Metastasis of Pancreatic Cancer Cells In Vitro and In Vivo Through Altering Cell Metabolism
- vitro+vivo, PC, NA
Hif1a↓, NF-kB↓, GLUT1↓, GLUT4↓, HK2↓, LDHA↓, TumCCA↑, TumMeta↓, GlucoseCon↓, ATP↓, necrosis↑, Casp∅, p‑FAK↓, MMP9↓, MUC4↓,
1232- Gra,    Graviola: A Systematic Review on Its Anticancer Properties
- Review, Var, NA
EGFR↓, cycD1/CCND1↓, Bcl-2↓, TumCCA↑, Apoptosis↑, ROS↑, MMP↓, BAX↑, Cyt‑c↑, Hif1a↓, NF-kB↓, GLUT1↓, GLUT4↓, HK2↓, LDHA↓, ATP↓,
7482- H2,    Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive, and Therapeutic Application
- Review, Var, NA - Review, IBD, NA - Review, Stroke, NA - Review, Sepsis, NA - Review, AD, NA
Dose↝, *Inflam↓, *IL1β↓, *IL6↓, *TNF-α↓, *neuroP↑, *mTOR↓, *IL10↑, *TGF-β↑, *Sepsis↓, *NRF2↑, *antiOx↑, *Catalase↑, *SOD↑, *GPx↑, *ROS↓, *HO-1↑, *PI3K↑, *Akt↑, *hepatoP↑, *MPO↓, *cardioP↑, CDK4↓, CDK6↑, CD47↓, PI3K↓, Akt↓, Hif1a↓, selectivity↑, *MMP↑, *ATP↑, *ER Stress↓, *CHOP/DDIT3↓, *Casp12↓, *GRP78/BiP↓, *p38↓, *p‑JNK↓, *LC3‑Ⅱ/LC3‑Ⅰ↑, *p‑eIF2α↓, *ATF4↓, *XBP-1↓, *Imm↑, *IFN-γ↓, *IL4↓, *GranB/GZMB↓, NK cell↑, radioP↑, *CD4+↑, CD8+↑, *Dose↝, *other↑, *Dose↝, *antiPs↑, *BioAv↝, *GutMicro↑, Dose↝, *IBI↑, TumCP↓, TumCI↓, TumCMig↓, CD8+↑, PGC-1α↑, Akt↓, SCD1↓, *MDA↓, Synergy↑, *APP↓, *BACE/β-secretase↓, *Aβ↓, *cognitive↑, *neuroP↑, NP/CIPN↓, *Stroke↓, *NLRP3↓, *ALAT↓, *AST↓, *LPS↓, *hepatoP↑, chemoP↑, *creat↓, *Urea↓, *RenoP↑, *eff↑, Apoptosis↑, XIAP↓, IAP2/BIRC3↓, TumVol↓, MALAT1↓, EZH2↓, miR-124-3p↓, eff↑, ChemoSen↑, *compII↑, *compIII↑, *LDL↓, *Obesity↓, QoL↑, PFS↑, *antiAll↑,
7483- H2,  Cisplatin,    Molecular hydrogen attenuates cisplatin-induced nephrotoxicity by modulating β-hydroxybutyrate metabolism
- in-vivo, Nor, HK-2
RenoP↑, BHB↑, HMGCS2↑, chemoP↑, *IL2↓, *IL6↓, *MCP1/CCL2↓, *TNF-α↓, *KeyT↝, *Inflam↓, *ROS↓, *MMP↑, *ATP↑, *MFN2↑, *PGC-1α↑, *BUN↓, *creat↓,
3767- H2,    The role of hydrogen therapy in Alzheimer's disease management: Insights into mechanisms, administration routes, and future challenges
- Review, AD, NA
*Inflam↓, *neuroP↑, *toxicity↓, *antiOx↑, *ROS↓, *NLRP3↓, *IL1β↓, *mtDam↓, *ATP↑, *AMPK↑, *FOXO3↑, *SOD1↑, *Catalase↑, *NRF2↑, *NO↓, *MDA↓, *lipid-P↓, *memory↑, *ER(estro)↓, *BDNF↑, *cognitive↑, *APP↓, *BACE/β-secretase↓, *Aβ↓, *BP∅, *BBB↑,
2512- H2,    Hydrogen Attenuates Allergic Inflammation by Reversing Energy Metabolic Pathway Switch
- in-vivo, Asthma, NA
*selectivity↑, *lactateProd↓, *ATP↑, *HK2↓, *PFK↓, *Hif1a↓, *PGC-1α↑, *Glycolysis↓, *OXPHOS↑, *Dose↝, *antiAll↑,
7503- H2S,    Hydrogen Sulfide, an Endogenous Stimulator of Mitochondrial Function in Cancer Cells
- Review, Var, NA
DNArepair↑, CBS↑, 3MST/MPST↑, ETC↑, ATP↑, Glycolysis↑, ACLY↑,
2879- HNK,    Honokiol Inhibits Lung Tumorigenesis through Inhibition of Mitochondrial Function
- in-vitro, Lung, H226 - in-vivo, NA, NA
tumCV↓, selectivity↑, TumCP↓, TumCCA↑, Apoptosis↑, mt-ROS↑, Casp3↑, Casp7↑, OCR↓, Cyt‑c↑, ATP↓, mitResp↓, AMP↑, AMPK↑,
2887- HNK,    Honokiol Restores Microglial Phagocytosis by Reversing Metabolic Reprogramming
- in-vitro, AD, BV2
*Glycolysis↑, *ATP↑, *ROS↓, *MMP↑, *OXPHOS↑, *PPARα↑, *PGC-1α↑,
960- HNK,    Honokiol Inhibits HIF-1α-Mediated Glycolysis to Halt Breast Cancer Growth
- vitro+vivo, BC, MCF7 - vitro+vivo, BC, MDA-MB-231
OCR↑, ECAR↓, GlucoseCon↓, lactateProd↓, ATP↓, Glycolysis↓, Hif1a↓, GLUT1↓, HK2↓, PDK1 / PDPK1↓, Apoptosis↑, LDHA↓,
886- HPT,    Impact of hyper- and hypothermia on cellular and whole-body physiology
- Analysis, Var, NA
MMP↓, OXPHOS↓, ATP↓, ROS↑, Apoptosis↑, Cyt‑c↑,
7775- IBC,    Isobavachalcone Induces Multiple Cell Death in Human Triple-Negative Breast Cancer MDA-MB-231 Cells
- vitro+vivo, BC, MDA-MB-231
TumCP↓, Apoptosis↑, Necroptosis↑, TumAuto↑, Akt↓, BAX↑, cl‑Casp3↑, RIP3↑, p‑RIP3↑, MLKL↑, LC3‑Ⅱ/LC3‑Ⅰ↑, mtDam↑, ATP↓, ROS↑, TumCG↓,
7636- Ins,    Myo-Inositol: Pharmacokinetics, Biological Functions, and Therapeutic Potential in Liver Protection: Insights from Preclinical Models
- Review, Nor, NA
*glucose↝, *lipid-P↓, *ROS↓, *BioAv↑, *hepatoP↑, *Inflam↓, *MMP↑, *ATP↑, *GutMicro↑, *Dose↝, *Half-Life↝, *BioAv↑, *Synergy↑, *hepatoP↑, *SOD↑, *Catalase↑, *Casp3↓, *ALAT↓, *AST↓, *AMPK↑, *SREBP1/SREBF1↑, NA↑,
7744- ISL,    Isoliquiritigenin suppresses fatty acid synthesis and cancer cell migration in anaplastic thyroid carcinoma through AMPK/SREBF1 pathway
- vitro+vivo, Thyroid, NA
AntiTum↑, TumCP↓, TumCMig↓, E-cadherin↑, N-cadherin↓, FASN↓, SREBP1/SREBF1↓, ATP↓, p‑AMPK↑, lipidLev↓, TumCG↓, lipoGen↓,
7755- ISL,    Isoliquiritigenin attenuated cognitive impairment, cerebral tau phosphorylation and oxidative stress in a streptozotocin-induced mouse model of Alzheimer's disease
- in-vivo, AD, NA
*memory↑, *p‑T-cadherin↓, *ROS↓, *ATP↑, *p‑DRP1/DNM1L↝, *MFN1↝, *MFN2↝, *neuroP↑, *cognitive↑, *mTOR↓, *ERK↓, *GSK‐3β↑,
7758- ISL,    Targeting the JAK/STAT pathway with isoliquiritigenin in ovarian cancer: molecular mechanisms and therapeutic implications
- Review, Ovarian, NA
JAK↓, STAT↓, toxicity↓, *antiOx↑, *ROS↓, *NRF2↑, *ARE↑, *HO-1↑, *NQO1↑, *Inflam↓, *NF-kB↓, *MAPK↓, *SOD↑, *Catalase↑, *GPx↑, *AntiViral↑, *NADPH↑, ROS↓, p38↓, mTOR↓, STAT3↓, cycD1/CCND1↓, survivin↓, p38↑, MAPK↑, mtDam↑, ER Stress↑, ROS↑, Apoptosis↑, GLUT4↓, ATP↓, Glycolysis↓, eff↑,
7816- ISQ,    Isoquercitrin Induces Endoplasmic Reticulum Stress and Immunogenic Cell Death in Gastric Cancer Cells
- in-vitro, GC, AGS - in-vitro, GC, HGC27
TumCP↑, Bcl-2↓, BAX↑, cl‑Casp3↑, Casp12↑, MMP↓, CRT↑, e-ATP↑, HMGB1↑, HSP70/HSPA5↑, HSP90↑, ER Stress↑,
7983- itraC,    Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells
- in-vitro, Nor, HUVECs
angioG↓, VDAC1↓, mt-ATP↓, AMPK↑, mTOR↓, TumCP↓,
8028- IVM,    Ivermectin as an Alternative Anticancer Agent: A Review of Its Chemical Properties and Therapeutic Potential
- Review, Var, NA
*BioAv↝, Apoptosis↑, TumCP↓, Wnt↓, β-catenin/ZEB1↓, TumCG↓, TumMeta↓, PI3K↓, Akt↓, mTOR↓, TumPF↓, CSCs↓, eff↑, ChemoSen↑, mtDam↑, MMP↓, ATP↓, ROS↑, NF-kB↓, BAX↑, Casp3↑, Casp9↑, ICD↑, Ki-67↓, PSA↓, YAP/TEAD↓,
8027- IVM,    Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin
- Review, Var, NA
*AntiP↑, TumCD↑, PAK1↑, TumAuto↑, Casp↑, ICD↑, TCF↝, Hippo↓, Akt↓, mTOR↓, angioG↓, CSCs↓, MMP↓, Cyt‑c↑, Apoptosis↑, BAX↑, P53↑, Bcl-2↓, cycE/CCNE↓, cycD1/CCND1↓, CDK2↓, CDK6↓, CDK4↓, YAP/TEAD↓, TFE3↑, mTORC1↓, mitResp↓, OCR↓, compI↓, MMP↓, ROS↑, SOD2↑, ATP↓, eff↓, mitA↓, P-gp/ABCB1↓, TumVol↓,
8022- IVM,    Antibiotic ivermectin preferentially targets renal cancer through inducing mitochondrial dysfunction and oxidative damage
- vitro+vivo, RCC, NA
AntiP↑, TumCP↓, Apoptosis↑, selectivity↑, TumCG↓, MMP↓, mitResp↓, ATP↓, ROS↑, eff↓,
8047- IVM,    The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug
- Review, Var, NA
Half-Life↝, MDR1↓, P-gp/ABCB1↓, mtDam↑, ROS↑, OCR↓, compI↓, MMP↓, mt-SOD↑, ATP↓, p‑Akt↓, p‑mTOR↓, eff↓, ICD↑, TumAuto↑, PAK1↓, Wnt↓, TCF↓, Nanog↓, SOX2↓, CSCs↓, CD44↓, CD24↓, Dose↝,
8040- IVM,    Ivermectin, a potential anticancer drug derived from an antiparasitic drug
- Review, Var, NA
Akt↓, mTOR↓, TumAuto↑, TumCP↓, TumCCA↑, Wnt↓, YAP/TEAD↓, MMP↓, mitResp↓, ATP↓, eff↓, eff↑, ROS↑, ChemoSen↑, PAK1↓, MAPK↓, EMT↓, Beclin-1/ATG6↑, ATG5↑, CSCs↓, STAT3↝, P-gp/ABCB1↓, MDR1↓, HSP27↓, Chl↑, TFE3↑,
1070- IVM,    Ivermectin accelerates autophagic death of glioma cells by inhibiting glycolysis through blocking GLUT4 mediated JAK/STAT signaling pathway activation
- vitro+vivo, GBM, NA
TumCG↓, LC3II↑, p62↓, ATP↓, Pyruv↓, GlucoseCon↑, HK2↓, PFK1↓, GLUT4↓, Glycolysis↓, JAK2↓, p‑STAT3↓, p‑STAT5↓,
7910- IVT,    Isovitexin potentiated the antitumor activity of cisplatin by inhibiting the glucose metabolism of lung cancer cells and reduced cisplatin-induced immunotoxicity in mice
- vitro+vivo, Lung, A549 - vitro+vivo, Lung, H1975
TumCG↓, GlucoseCon↓, lactateProd↓, ATP↓, PKM2↓, ChemoSen↑,
8089- KAE,    Kaempferol impairs aerobic glycolysis against melanoma metastasis via inhibiting the mitochondrial binding of HK2 and VDAC1
- in-vitro, Melanoma, A375 - in-vitro, Melanoma, B16-F10
TumCMig↓, TumCI↓, TumMeta↓, ECAR↓, GlucoseCon↓, ATP↓, Pyruv↓, lactateProd↓, HK2↓, VDAC1↓, Akt↓, GSK‐3β↝, Glycolysis↓,
8092- KAE,    Kaempferol Reverses Aerobic Glycolysis via miR-339-5p-Mediated PKM Alternative Splicing in Colon Cancer Cells
- in-vitro, Colon, HCT116 - in-vitro, Colon, DLD1
TumCP↓, TumCCA↑, Apoptosis↑, GlucoseCon↓, lactateProd↓, ATP↓, miR-339-5p↑, Glycolysis↓, PKM2↓, PKM1↑,
8067- KAE,  Cisplatin,    Kaempferol Induces Cell Death and Sensitizes Human Head and Neck Squamous Cell Carcinoma Cell Lines to Cisplatin
- in-vitro, HNSCC, NA
AntiCan↑, OCR↓, i-ATP↓, TumCMig↓, TumCP↓, Apoptosis↑, ChemoSen↑,
8162- LapC,    Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2
- in-vitro, Melanoma, MEL526 - in-vitro, Melanoma, MEL697 - in-vitro, Melanoma, MEL103
Glycolysis↓, OCR↑, PKM2↓, ATP↓, TumCP↓, Apoptosis↑, OXPHOS↑, Dose↝,
8178- Las,    Lasiokaurin suppresses breast cancer growth by blocking autophagic flux and regulating cellular energy homeostasis
- in-vitro, BC, NA
Akt↓, mTOR↓, PDK1 / PDPK1↓, ATP↓, TumCD↑,
8237- LCA,    Role of Licochalcone A in Potential Pharmacological Therapy: A Review
- Review, Var, NA
*other↝, *Inflam↓, *Bacteria↓, *antiOx↑, *AntiP↑, *neuroP↑, *glucose↝, *lipid-P↓, PKCδ↓, P70S6K↓, Akt↓, ER Stress↑, Apoptosis↑, Ca+2↑, PI3K↓, mTOR↓, Casp3↑, Bcl-2↓, Cyt‑c↑, BAX↑, cl‑PARP↑, cycD1/CCND1↑, ROS↑, CHOP/DDIT3↑, ERK↑, p38↑, JNK↓, IAP1↓, XIAP↓, survivin↓, cFLIP↓, RIP1↓, EGFR↓, MET↓, HER2/EBBR2↓, p‑4E-BP1↓, PERK↑, eIF2α↑, PD-L1↓, HK2↓, Glycolysis↓, Sp1/3/4↓, FasL↑, MMP↓, ATP↓, TumAuto↑, WEE1↑, P21↑, CDK1↓, TumCCA↑, TumCMig↓, TumCI↓, ABCG2↓, HSP90↓, T-Cell↑, CD4+↑, CD25+↑, FOXP3↑, Imm↝, *Inflam↓, *NF-kB↓, *NRF2↑, *AntiArt↑, *antiAll↑, *MUC5AC↓, *E-sel↓, *CCL11↓,
8235- LCA,    Anticancer effects of licochalcones: A review of the mechanisms
- Review, Var, NA
mt-Apoptosis↑, TumAuto↑, TumCMig↓, LC3‑Ⅱ/LC3‑Ⅰ↑, ATG5↑, ATG7↑, p62↑, CHOP/DDIT3↑, ER Stress↑, UPR↑, ATG3↑, Beclin-1/ATG6↑, ATG16L1↑, PERK↑, ATF4↑, ATP↓, Hif1a↓, GLUT1↓, PDK1 / PDPK1↓, Bcl-xL↓, Bcl-2↓, BAD↑, BAX↑, Casp3↑, survivin↓, EGFR↓, ERK↓, Akt↓, mtDam↑, MMP↓, Cyt‑c↑, Casp↑, MDM2↓, CycB/CCNB1↓, CDC2↓, CDC25↓, TumCCA↑, TumCP↓, Wnt↓, β-catenin/ZEB1↓, Sp1/3/4↓, MMP-10↓, MMP3↓, TumCI↓, Imm↑, PD-L1↓, ROS↑, 4E-BP1↓, eIF2α↓, PI3K↓, mTOR↓, p‑cMET↑, Ca+2↑, RUBCN↓, ATG13↑, TSC1↑, TSC2↑, PRAS40↑, PP2A↑, ULK1/ATG1↑, THEM4/CTMP↑, DR5↑, Fas↑, TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, PKCδ↓, P70S6K↓, VEGF↓, angioG↓, HK2↓, Glycolysis↓, TrxR1↓, APAF1↑, cl‑PARP↑, Bax:Bcl2↑, ABCG2↓, BioEnh↑,
8213- LCA,    Licochalcone A inhibits hypoxia-inducible factor-1α accumulation by suppressing mitochondrial respiration in hypoxic cancer cells
- in-vitro, CRC, HCT116 - in-vitro, Lung, H1299 - in-vitro, Lung, H322
Hif1a↓, GLUT1↓, PDK1 / PDPK1↓, ROS↑, mitResp↓, ATP↓, tumCV?,
8332- LIN,    Linalool decreases HepG2 viability by inhibiting mitochondrial complexes I and II, increasing reactive oxygen species and decreasing ATP and GSH levels
- in-vitro, Liver, HepG2 - in-vitro, Colon, Caco-2 - in-vitro, NA, NIH-3T3 - in-vitro, BC, MCF7 - in-vitro, Nor, HEK293
compI↓, compII↓, ATP↓, GSH↓, ROS↑,

Showing Research Papers: 101 to 150 of 257
Prev Page 3 of 6 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 257

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 1,   ARE↓, 1,   Catalase↓, 3,   Catalase↑, 2,   Fenton↑, 2,   GPx↓, 2,   GPx↑, 1,   GPx4↓, 4,   GSH↓, 24,   GSH↑, 1,   GSH/GSSG↓, 2,   GSTs↑, 1,   H2O2↑, 2,   HO-1↓, 1,   HO-1↑, 3,   Iron↑, 4,   lipid-P↓, 1,   lipid-P↑, 8,   MDA↑, 5,   i-MDA↑, 1,   NADH↓, 2,   NQO1↑, 1,   NRF2↓, 3,   NRF2↑, 6,   ROS↓, 7,   ROS↑, 128,   ROS⇅, 1,   ROS↝, 1,   mt-ROS↑, 4,   SOD↓, 4,   SOD↑, 2,   mt-SOD↑, 1,   SOD1↓, 1,   SOD2↑, 1,   TAC↓, 1,   Thiols↓, 1,   Trx↓, 1,   Trx1↓, 2,   TrxR↓, 3,   TrxR1↓, 1,   xCT/SLC7A11↓, 4,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

Zn2+↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   CDC2↓, 1,   CDC25↓, 1,   compI↓, 11,   compII↓, 4,   compIII↓, 2,   compIII↑, 1,   compIV↓, 1,   compV↓, 1,   ETC↓, 6,   ETC↑, 1,   Insulin↓, 1,   MCU↓, 1,   mitResp↓, 14,   mitResp↑, 2,   mtDam↑, 23,   OCR↓, 14,   OCR↑, 7,   OXPHOS↓, 18,   OXPHOS↑, 7,   OXPHOS↝, 2,   mt-OXPHOS↓, 4,   PDH↓, 5,   PDH↑, 2,   PGC-1α↑, 1,   VDAC1↓, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

3MST/MPST↑, 1,   ACLY↓, 1,   ACLY↑, 1,   adiP↑, 1,   ALAT↓, 2,   ALDOA↓, 1,   ALDOB↑, 1,   AminoA↓, 1,   AMP↑, 3,   AMPK↑, 15,   p‑AMPK↑, 3,   ATP↓, 170,   ATP↑, 7,   ATP⇅, 1,   ATP↝, 3,   ATP∅, 2,   e-ATP↑, 1,   i-ATP↓, 3,   i-ATP↑, 1,   mt-ATP↓, 2,   ATP:AMP↓, 1,   BHB↑, 1,   CAIX/CA9↓, 1,   CBS↑, 1,   ECAR↓, 8,   ECAR↑, 1,   ENO1↓, 2,   ENO3↑, 1,   FAO↓, 2,   FAO↑, 1,   FASN↓, 4,   FBP1↑, 1,   FBPase↑, 1,   G6PD↓, 1,   GAPDH↓, 4,   GLO-I↓, 1,   GLS↓, 1,   glucoNG↓, 2,   glucoNG↑, 1,   glucose↓, 2,   GlucoseCon↓, 31,   GlucoseCon↑, 1,   GlutaM↓, 2,   GlutMet↓, 1,   glyC↓, 1,   Glycolysis↓, 69,   Glycolysis↑, 1,   GSK‐3β↓, 1,   GSK‐3β↑, 2,   GSK‐3β↝, 1,   HK1↓, 3,   HK2?, 1,   HK2↓, 41,   HK3↑, 1,   HMG-CoA↓, 2,   HMGCS2↑, 1,   lactateProd↓, 34,   lactateProd↑, 2,   e-lactateProd↓, 1,   LDHA↓, 17,   lipidLev↓, 1,   lipoGen↓, 3,   MCT4↓, 1,   NAD↓, 3,   NADPH↓, 4,   PCK1↑, 1,   PDK1 / PDPK1↓, 11,   PDK3↑, 1,   PFK↓, 5,   PFK1↓, 4,   PFK2↓, 1,   PFKP↓, 1,   PGK1↓, 2,   PGK2↑, 1,   PGM1↓, 1,   PGM1↑, 1,   PGM3↑, 1,   PKLR↑, 1,   PKM1↑, 2,   PKM2↓, 21,   PKM2↑, 1,   PPP↓, 2,   Pyruv↓, 2,   Pyruv↑, 1,   p‑S6↓, 1,   SCD1↓, 2,   SIRT1↓, 1,   SIRT1↑, 2,   SREBP1/SREBF1↓, 2,   SREBP2↓, 1,   TCA↓, 3,   TCA↑, 3,   Warburg↓, 17,   β-oxidation↓, 1,  

Cell Death(tgid=5) ⓘ

AIF↑, 6,   APAF1↑, 1,   Apoptosis?, 3,   Apoptosis↑, 79,   mt-Apoptosis↑, 2,   BAD↑, 2,   Bak↓, 1,   Bak↑, 1,   BAX↓, 2,   BAX↑, 18,   Bax:Bcl2↑, 6,   Bcl-2↓, 24,   Bcl-xL↓, 3,   BID↑, 1,   BNIP3?, 1,   BNIP3↝, 1,   Casp↑, 15,   Casp∅, 1,   Casp12↑, 1,   Casp2↑, 1,   Casp3↓, 3,   Casp3↑, 32,   cl‑Casp3↑, 8,   Casp7↑, 4,   Casp8↑, 5,   cl‑Casp8↑, 1,   Casp9↑, 14,   cl‑Casp9↑, 3,   cFLIP↓, 1,   Cupro↑, 1,   Cyt‑c↓, 1,   Cyt‑c↑, 25,   DR5↑, 1,   FADD↑, 1,   Fas↑, 5,   FasL↑, 1,   Ferroptosis↓, 1,   Ferroptosis↑, 7,   GSDMC↑, 1,   GSDME-N↑, 1,   IAP1↓, 1,   IAP2/BIRC3↓, 1,   ICD↑, 5,   iNOS↓, 1,   iNOS↑, 1,   Mcl-1↓, 7,   MDM2↓, 2,   MLKL↑, 2,   MOMP↑, 4,   Necroptosis↑, 3,   necrosis↑, 5,   NOXA↑, 1,   p38↓, 2,   p38↑, 6,   PUMA↑, 1,   Pyro↑, 2,   RIP3↑, 1,   p‑RIP3↑, 2,   survivin↓, 11,   TumCD↑, 11,   XIAP↓, 4,   XIAP↑, 1,   YAP/TEAD↓, 3,   YAP/TEAD↑, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 44,   Akt↑, 1,   p‑Akt↓, 7,   p‑Akt↑, 1,   AKT1↓, 2,   AMPKα↑, 1,   CK2↓, 1,   p‑cMET↑, 1,   EGFR↓, 9,   EGFR↑, 1,   ERK↓, 10,   ERK↑, 3,   p‑ERK↓, 3,   FOXD3↑, 1,   HER2/EBBR2↓, 5,   Hippo↓, 1,   IGF-1R↓, 2,   JAK↓, 2,   JAK2↓, 3,   JNK↓, 2,   JNK↑, 4,   p‑JNK↓, 1,   p‑JNK↑, 1,   MAPK↓, 5,   MAPK↑, 4,   p‑MAPK↓, 1,   MEK↓, 1,   mTOR↓, 27,   p‑mTOR↓, 3,   mTORC2↓, 1,   P70S6K↓, 3,   p‑P70S6K↓, 2,   PHKG1↑, 1,   PI3K↓, 23,   PI3K↑, 1,   p‑PI3K↓, 2,   PI3K/Akt↓, 2,   PKA↓, 2,   PKCδ↓, 3,   PP2A↑, 1,   PRAS40↑, 1,   PTEN↑, 3,   Raf↓, 2,   RAS↓, 1,   RIP1↓, 1,   p‑S6K↓, 2,   Sp1/3/4↓, 4,   STAT↓, 1,   STAT3↓, 13,   STAT3↝, 1,   p‑STAT3↓, 2,   STAT5↓, 1,   p‑STAT5↓, 1,   THEM4/CTMP↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF3↓, 1,   ATF4↑, 1,   cJun↓, 1,   cJun↑, 1,   cMyc↓, 9,   DNMT1↓, 1,   DNMTs↓, 1,   EZH2↓, 1,   FOXO3↑, 1,   FOXO4↓, 1,   H3↓, 1,   ac‑H3↑, 1,   H3K9↓, 1,   ac‑H4↑, 1,   HATs↓, 1,   HATs↑, 1,   HDAC↓, 7,   HDAC2↓, 1,   HDAC3↓, 1,   HDAC4↓, 1,   HDAC8↓, 2,   HMTs↓, 2,   miR-124-3p↓, 1,   miR-203↑, 1,   miR-339-5p↑, 1,   miR-34a↓, 1,   miR-34a↑, 1,   miR-375↑, 1,   Myc↓, 1,   n-MYC↓, 1,   OCT4↓, 1,   other↓, 2,   other↑, 4,   other↝, 7,   OV6↓, 1,   SOX2↓, 3,   SOX9↓, 1,   SUV39H↓, 1,   TFE3↑, 2,   tumCV?, 1,   tumCV↓, 17,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 4,   CRT↑, 1,   i-CRT↓, 1,   CUL1↝, 1,   CUL5↝, 1,   eIF2α↓, 1,   eIF2α↑, 1,   ER Stress↑, 17,   HSP27↓, 2,   HSP70/HSPA5↓, 1,   HSP70/HSPA5↑, 1,   HSP72↓, 1,   HSP90↓, 2,   HSP90↑, 1,   NQO2↑, 1,   PERK↑, 2,   UPR↑, 2,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG16L1↑, 1,   ATG3↑, 2,   ATG5↑, 2,   ATG5↝, 1,   ATG7↑, 1,   autoF↓, 2,   Beclin-1/ATG6↓, 2,   Beclin-1/ATG6↑, 5,   Beclin-1/ATG6↝, 1,   p‑Beclin-1/ATG6↑, 1,   CTSB↓, 1,   CTSD↓, 1,   CTSL↑, 1,   LAMP2↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 4,   LC3B-II↑, 1,   LC3II↑, 3,   lysoMP↑, 1,   lysosome↓, 1,   lysosome↝, 1,   MitoP↑, 1,   p62↓, 5,   p62↑, 2,   RUBCN↓, 1,   TumAuto↑, 27,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 2,   p‑ATM↑, 2,   DNAdam↑, 22,   mt-DNAdam↑, 1,   DNArepair↑, 1,   hTERT/TERT↓, 3,   P53↓, 2,   P53↑, 16,   P53↝, 1,   p‑P53↑, 1,   p53 Wildtype∅, 1,   PARP↓, 1,   PARP↑, 5,   cl‑PARP↓, 1,   cl‑PARP↑, 11,   cl‑PARP1↑, 1,   PCNA↓, 7,   POLD1↓, 1,   Telomerase↓, 3,   TOP1?, 1,   TOP1↓, 2,   TP53↓, 2,   TP53↑, 1,   TRF2↓, 1,   γH2AX↑, 5,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 3,   CDK2↓, 6,   CDK4↓, 8,   CDK6↓, 3,   CDK6↑, 1,   Cyc↓, 1,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 4,   cycD1/CCND1↓, 12,   cycD1/CCND1↑, 2,   cycE/CCNE↓, 3,   cycE/CCNE↑, 1,   Ki-67↓, 8,   mitA↓, 1,   mitA↑, 1,   P21↓, 3,   P21↑, 9,   p27/CDKN1B↑, 6,   TumCCA↑, 48,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   p‑4E-BP1↓, 1,   ALDH↓, 4,   CD133↓, 2,   CD24↓, 2,   CSCs?, 1,   CSCs↓, 19,   CSCs↑, 1,   CSCsMark↓, 1,   Diff↓, 1,   FGF↓, 1,   Gli1↓, 2,   HMGCR↓, 1,   IGF-1↓, 5,   IGFBP1↑, 1,   IGFBP3↑, 1,   Ki-67↓, 8,   mTORC1↓, 2,   p‑mTORC1↓, 1,   Nanog↓, 1,   Nestin↓, 1,   NOTCH↓, 4,   NOTCH1↓, 2,   NOTCH1↑, 1,   PTCH1↓, 1,   Shh↓, 1,   Smo↓, 2,   TumCG↓, 41,   TumCG↑, 2,   TumCP↓, 57,   TumCP↑, 2,   Wnt↓, 9,   Wnt/(β-catenin)↓, 1,   Zn2+↑, 1,  

Migration(tgid=13) ⓘ

AP-1↓, 1,   ATPase↓, 1,   BACH1↓, 1,   CA↓, 1,   Ca+2↓, 1,   Ca+2↑, 22,   Ca+2↝, 1,   i-Ca+2↑, 1,   Chl↑, 1,   E-cadherin↑, 8,   EMT↓, 17,   EpCAM↓, 1,   FAK↓, 3,   p‑FAK↓, 2,   Fibronectin↓, 1,   Furin↓, 1,   GLI2↓, 1,   ITGB1↓, 1,   ITGB6↓, 1,   LAMs↓, 1,   MALAT1↓, 1,   MET↓, 1,   MMP-10↓, 1,   MMP2↓, 11,   MMP3↓, 2,   MMP9↓, 13,   MMP9↑, 1,   MMPs↓, 5,   MUC4↓, 1,   N-cadherin↓, 2,   PAK1↓, 2,   PAK1↑, 1,   PDGF↓, 1,   Rho↓, 3,   ROCK1↓, 1,   Slug↓, 3,   SMAD2↓, 1,   SMAD3↓, 1,   Snail↓, 6,   SPARC↑, 2,   STAC2↓, 1,   TGF-β↓, 5,   TIMP1↓, 1,   TIMP1↑, 2,   TIMP2↑, 1,   TRIB3↑, 1,   TSC1↑, 1,   TumCA↓, 1,   TumCA↑, 1,   TumCI↓, 21,   TumCI↑, 1,   TumCMig↓, 20,   TumCMig↑, 1,   TumMeta↓, 16,   TumMeta↑, 2,   TumPF↓, 2,   Twist↓, 1,   uPA↓, 3,   uPAR↓, 1,   Vim?, 1,   Vim↓, 2,   Zeb1↓, 3,   β-catenin/ZEB1↓, 5,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 17,   angioG↑, 1,   CD31/PECAM-1↓, 2,   eNOS↓, 1,   eNOS↑, 1,   HIF-1↓, 4,   Hif1a↓, 29,   Hypoxia↓, 1,   NO↑, 4,   VEGF↓, 21,   VEGFR1↓, 1,   VEGFR2/KDR/Flk1↓, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   CellMemb↑, 1,   CTR1↑, 1,   CX43/GJA1↓, 1,   EPR↑, 1,   GLUT1↓, 22,   GLUT2↓, 1,   GLUT4↓, 5,   MMP↓, 62,   MMP↑, 3,   MPT↑, 4,   NHE1↓, 1,   SVCT-2∅, 1,   TRPM7↓, 1,   TRPV1↑, 1,   TRPV2↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCR7↓, 1,   CD25+↑, 1,   CD4+↑, 2,   CD44↓, 3,   CD47↓, 1,   CD8+↑, 7,   COX2/PTGS2↓, 13,   COX2/PTGS2↑, 1,   CXCR4↓, 1,   DCells↑, 1,   DR4↑, 1,   FOXP3↑, 1,   HLA-I/II↑, 1,   HMGB1↓, 2,   HMGB1↑, 2,   i-HMGB1↓, 1,   ICAM-1↓, 1,   IFN-γ↓, 1,   IFN-γ↑, 1,   IL1↓, 1,   IL10↓, 2,   IL12↑, 1,   IL17↓, 1,   IL1β↓, 2,   IL2↑, 1,   IL4↓, 1,   IL6↓, 7,   IL8↓, 1,   Imm↑, 6,   Imm↝, 1,   Inflam↓, 8,   pol-M1↑, 1,   M2 MC↓, 1,   pol-M2 MC↓, 1,   MCP1/CCL2↓, 1,   MCT1↓, 1,   NF-kB↓, 22,   NF-kB↑, 2,   p‑NF-kB↓, 1,   NK cell↑, 3,   p65↓, 2,   PD-1↓, 2,   PD-L1↓, 5,   PGE2↓, 5,   PSA↓, 3,   T-Cell↑, 1,   TCF↓, 1,   TCF↝, 1,   Th1 response↑, 1,   TLR4↓, 2,   TNF-α↓, 5,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,   Treg lymp↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

e-pH↑, 1,   i-pH↓, 2,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 3,   AR↑, 1,   ER-α36↓, 2,   PPARγ↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 2,   BioAv↓, 9,   BioAv↑, 11,   BioAv↝, 7,   BioEnh↑, 1,   ChemoSen↓, 2,   ChemoSen↑, 45,   CYP1A1↑, 2,   CYP1A2↑, 1,   CYP2A3/CYP2A6↓, 1,   CYP2E1↑, 1,   CYP3A4↓, 1,   DDS↑, 1,   Dose?, 2,   Dose↓, 2,   Dose↑, 4,   Dose↝, 22,   Dose∅, 3,   eff↓, 24,   eff↑, 46,   eff↝, 6,   GSTZ1↓, 1,   Half-Life↓, 4,   Half-Life↝, 2,   MDR1↓, 2,   P-gp/ABCB1↓, 9,   P-gp/ABCB1↑, 1,   P450↓, 1,   RadioS↑, 12,   selectivity↑, 32,   selectivity∅, 1,   Synergy↑, 29,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   AR↓, 3,   AR↑, 1,   AST↓, 1,   BG↓, 2,   BloodF↑, 1,   BMD↑, 1,   CEA↓, 1,   CRP↓, 1,   EGFR↓, 9,   EGFR↑, 1,   EZH2↓, 1,   HER2/EBBR2↓, 5,   hTERT/TERT↓, 3,   IL6↓, 7,   LDH↓, 10,   LDH↑, 1,   p‑LDH↓, 1,   Myc↓, 1,   PD-L1↓, 5,   PSA↓, 3,   TG/TAG↓, 1,   TP53↓, 2,   TP53↑, 1,   TRIB3↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 15,   AntiTum↑, 6,   cardioP↑, 2,   chemoP↑, 6,   chemoPv↑, 1,   ChemoSideEff↓, 2,   fatigue↓, 1,   hepatoP↑, 2,   hepatoP∅, 1,   neuroP↑, 2,   NP/CIPN↓, 3,   OS↑, 6,   PFS↑, 1,   QoL↑, 2,   radioP↑, 1,   RenoP↑, 1,   Risk↓, 4,   toxicity↓, 10,   toxicity↑, 1,   toxicity↝, 5,   toxicity∅, 2,   TumVol↓, 6,   TumW↓, 3,   Weight∅, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiP↑, 1,   GutMicro↑, 3,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 1,  
Total Targets: 681

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 35,   ARE↑, 2,   Catalase↑, 20,   GPx↑, 17,   GPx1↑, 1,   GPx4↑, 1,   GSH↓, 1,   GSH↑, 18,   GSR↓, 1,   GSR↑, 1,   GSTs↑, 3,   H2O2↓, 3,   HO-1↓, 1,   HO-1↑, 14,   Iron↓, 1,   Keap1↓, 2,   Keap1↑, 1,   Keap1↝, 1,   lipid-P↓, 20,   mt-lipid-P↓, 1,   MDA↓, 11,   MDA↑, 1,   MPO↓, 3,   NADPH/NADP+↑, 1,   NQO1↑, 4,   Nrf1↑, 1,   NRF2?, 1,   NRF2↑, 25,   Prx↓, 1,   Prx↑, 1,   ROS↓, 57,   ROS↑, 5,   ROS∅, 1,   mt-ROS?, 1,   mt-ROS↓, 1,   mt-ROS↑, 1,   SAM-e↑, 1,   SOD↑, 21,   SOD1↑, 2,   SOD2↑, 2,   TAC↑, 1,   TBARS↓, 1,   Trx↑, 1,   uricA↓, 1,   VitC↑, 2,   VitE↑, 2,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,   Mets↝, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compI↓, 1,   compI↑, 3,   compII↑, 2,   compIII↓, 1,   compIII↑, 3,   compIV↑, 3,   DRP1/DNM1L↓, 2,   DRP1/DNM1L↑, 1,   p‑DRP1/DNM1L↝, 1,   ETC↓, 1,   ETC↑, 4,   FIS1↓, 3,   FIS1↑, 1,   Insulin↑, 1,   MFN1↑, 1,   MFN1↝, 1,   MFN2↓, 1,   MFN2↑, 4,   MFN2↝, 1,   mitResp↑, 6,   mtDam↓, 4,   OCR↑, 3,   mt-OCR↑, 1,   OPA1↓, 1,   OPA1↑, 2,   OXPHOS↑, 5,   PGC-1α↑, 10,   PGC-1α↝, 1,   PINK1↑, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 1,   mt-ACC⇅, 1,   Acetyl-CoA↑, 1,   ALAT↓, 7,   AMPK↓, 2,   AMPK↑, 8,   ATP↓, 6,   ATP↑, 62,   ATP↝, 1,   ATP∅, 1,   mt-ATP↑, 1,   ECAR↑, 1,   ECAR∅, 1,   FAO↑, 3,   FASN↓, 1,   G6PD↑, 1,   glucoNG↓, 1,   glucose↓, 3,   glucose↝, 3,   GlucoseCon↓, 1,   GlucoseCon↑, 5,   Glycolysis↓, 2,   Glycolysis↑, 2,   Glycolysis↝, 2,   GSK‐3β↓, 4,   GSK‐3β↑, 2,   HK2↓, 2,   KeyT↝, 1,   lactateProd↓, 2,   LDHA↓, 1,   LDHB↑, 1,   LDL↓, 2,   NAD↓, 1,   NAD↑, 1,   NAD↝, 1,   NADH:NAD↑, 1,   NADPH↓, 3,   NADPH↑, 3,   NH3↑, 1,   PDKs↑, 1,   PFK↓, 2,   PFK2↓, 1,   PGM1?, 1,   PKM1↑, 1,   PKM2↓, 1,   PKM2↑, 1,   PPP↓, 1,   SCFAs↑, 1,   SIRT1↑, 5,   SREBP1/SREBF1↑, 1,   TCA↑, 1,  

Cell Death(tgid=5) ⓘ

AIF↓, 2,   Apoptosis↓, 9,   BAX↓, 2,   BAX↑, 2,   Bax:Bcl2↓, 1,   Bcl-2↓, 3,   Bcl-2↑, 4,   Casp↓, 1,   Casp12↓, 1,   Casp3↓, 10,   Casp3↑, 3,   Casp9↓, 4,   Casp9↑, 2,   Cyt‑c↓, 3,   Cyt‑c∅, 1,   Ferroptosis↓, 2,   GranB/GZMB↓, 1,   GSDMD↓, 1,   iNOS↓, 8,   p38↓, 2,   YAP/TEAD↑, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 3,   Akt↑, 4,   CREB↑, 1,   ERK↓, 1,   Hippo↑, 1,   JAK2↑, 1,   p‑JNK↓, 2,   MAPK↓, 4,   mTOR↓, 3,   mTOR↑, 1,   p‑mTOR↑, 1,   PI3K↓, 3,   PI3K↑, 3,   PKA↑, 1,   PP2A↑, 1,   RAS↓, 1,   STAT↓, 1,   STAT3↑, 2,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF2↑, 1,   ATF4↓, 2,   FOXO↑, 1,   FOXO3↑, 2,   HDAC2↓, 1,   miR-34a↓, 1,   other?, 1,   other↑, 5,   other↝, 6,   SOX2↑, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 3,   p‑eIF2α↓, 1,   ER Stress↓, 2,   GRP78/BiP↓, 2,   GRP78/BiP↑, 1,   HSP70/HSPA5↝, 1,   UPR↑, 1,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG5↑, 1,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3II↓, 1,   LC3II↑, 2,   MitoP↑, 3,   p62↓, 1,   p62↑, 3,   PARK2↑, 2,  

DNA Damage & Repair(tgid=10) ⓘ

P53↓, 1,   PARP1↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

GADD34↓, 1,   Ki-67↑, 1,   P21↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

BMPs↑, 1,   Diff↑, 1,   HH↓, 1,   Ki-67↑, 1,   Nestin↑, 1,   neuroG↑, 2,   NOTCH1↑, 1,   TumCP↓, 1,   Wnt↑, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 2,   Ca+2↓, 3,   Ca+2↑, 3,   Ca+2↝, 2,   Cartilage↑, 1,   FAK↑, 1,   MMP13↓, 1,   MMP9↓, 1,   serineP↓, 1,   SMAD3↓, 1,   p‑T-cadherin↓, 1,   TGF-β↓, 2,   TGF-β↑, 1,   TIMP1↓, 1,   Vim↓, 1,   α-SMA↓, 1,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↑, 1,   E-sel↓, 1,   eNOS↑, 1,   Hif1a↓, 1,   NO↓, 3,   NO↑, 1,   VCAM-1↓, 2,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↓, 1,   BBB↑, 9,   BBB↝, 1,   GastroP↑, 2,   GLUT4↑, 1,   H+/K+-ATPase↓, 1,   IBI↑, 1,   memfluid↑, 1,   MMP↓, 4,   MMP↑, 15,   MUC5AC↓, 1,   TRPV3↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCL11↓, 1,   CD4+↑, 2,   CD8+↑, 1,   COX2/PTGS2↓, 7,   COX2/PTGS2↑, 1,   HMGB1↓, 1,   IFN-γ↓, 2,   IFN-γ↑, 1,   IL10↓, 3,   IL10↑, 1,   IL17↓, 3,   IL18↓, 1,   IL1β↓, 15,   IL2↓, 2,   IL33↓, 1,   IL4↓, 2,   IL6↓, 16,   IL6↑, 1,   IL8↓, 4,   Imm↓, 1,   Imm↑, 3,   INF-γ↓, 1,   Inflam↓, 44,   LPS↓, 1,   pol-M2 MC↑, 1,   MCP1/CCL2↓, 1,   NeuroI↓, 1,   NF-kB↓, 14,   NF-kB↑, 1,   p‑NF-kB↓, 1,   NK cell↑, 1,   NLRP3↓, 3,   p65↓, 1,   PGE2↓, 3,   TLR4↓, 1,   TNF-α↓, 22,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 2,   Ach↑, 3,   AChE↓, 9,   BChE↓, 2,   BDNF↓, 1,   BDNF↑, 5,   ChAT↑, 2,   DA↑, 1,   MAOA↓, 2,   MAOB↓, 1,   NGF↑, 2,   TrkB↑, 2,  

Protein Aggregation(tgid=19) ⓘ

APP↓, 5,   Aβ↓, 21,   Aβ42↓, 1,   BACE/β-secretase↓, 8,   tau↓, 2,   p‑tau↓, 8,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   ACE/ACE1↑, 1,   ACE2↓, 1,   ER(estro)↓, 1,   FGF21↑, 1,   PPARα↑, 2,   PPARγ↑, 3,   testos↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 5,   BioAv↑, 13,   BioAv↝, 8,   BioEnh↑, 1,   Dose↑, 1,   Dose↝, 12,   eff↓, 4,   eff↑, 9,   eff↝, 1,   Half-Life↓, 1,   Half-Life↝, 4,   P450↑, 1,   selectivity↑, 2,   Synergy↑, 9,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 7,   AST↓, 7,   BG↓, 1,   BloodF↑, 5,   BMD↑, 3,   BP↓, 2,   BP↝, 1,   BP∅, 1,   BUN↓, 1,   Calcium↑, 1,   creat↓, 3,   CRP↓, 3,   Hcy/homoC↓, 1,   hs-CRP↓, 1,   IL6↓, 16,   IL6↑, 1,   IRes↝, 1,   KeyT↝, 1,   LDH↓, 2,   Mag↑, 1,   NOS2↓, 2,   TC↓, 1,   TG/TAG↓, 1,   Urea↓, 1,   VitD↑, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 1,   AntiAge↑, 4,   antiAll↑, 6,   AntiArt↑, 2,   AntiCan↑, 3,   AntiDiabetic↑, 8,   antiPs↑, 2,   AntiTum↑, 1,   Bone Healing↑, 1,   cardioP↑, 14,   CardioT↓, 1,   chemoP↑, 3,   chemoPv↑, 3,   ChemoSideEff↓, 1,   cognitive↑, 23,   diuretic↑, 1,   hepatoP↓, 1,   hepatoP↑, 19,   Learn↑, 1,   memory↑, 15,   Mood↑, 1,   motorD↓, 1,   motorD↑, 6,   neuroP↑, 38,   Obesity↓, 6,   Pain↓, 2,   radioP↑, 1,   RenoP↑, 6,   Risk↓, 3,   Strength↑, 1,   Stress↓, 1,   Stroke↓, 6,   toxicity↓, 11,   toxicity↑, 2,   toxicity↝, 7,   toxicity∅, 3,   Weight↓, 1,   Wound Healing↑, 2,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 4,   AntiFungal↑, 2,   AntiP↑, 2,   AntiViral↑, 5,   Bacteria↓, 7,   Diar↓, 1,   GutMicro↑, 7,   Sepsis↓, 3,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↝, 1,  
Total Targets: 398

Scientific Paper Hit Count for: ATP, Adenosine triphosphate
11 3-bromopyruvate
9 Magnetic Fields
9 Vitamin C (Ascorbic Acid)
6 Silver-NanoParticles
6 Berberine
6 Citric Acid
6 Ivermectin
6 Resveratrol
6 Shikonin
5 Alpha-Lipoic-Acid
5 Graviola
5 Melatonin
5 Quercetin
5 salinomycin
4 Ashwagandha(Withaferin A)
4 Capsaicin
4 Curcumin
4 EGCG (Epigallocatechin Gallate)
4 Emodin
4 Hydrogen Gas
4 Luteolin
4 Metformin
4 Urolithin
3 2-DeoxyGlucose
3 Radiotherapy/Radiation
3 Apigenin (mainly Parsley)
3 Propolis -bee glue
3 immunotherapy
3 Crocetin
3 Copper and Cu NanoParticles
3 diet FMD Fasting Mimicking Diet
3 Honokiol
3 Isoliquiritigenin
3 Kaempferol
3 Licochalcone A
3 Linalool
3 Methylene blue
3 Rosmarinic acid
3 Sulforaphane (mainly Broccoli)
3 Silymarin (Milk Thistle) silibinin
3 Ursolic acid
2 Allicin (mainly Garlic)
2 DTS(dibenzyl trisulphide) from Anamu
2 chaetocin
2 Chrysin
2 Citicoline, CDP-Choline
2 Cucurbitacin
2 Diclofenac
2 Docosahexaenoic Acid
2 Chemotherapy
2 Ginkgo biloba-EGb 761
2 Formononetin
2 Galloflavin
2 Ginkgo biloba
2 Gossypol/AT-101
2 Cisplatin
2 Isovitexin
2 Matrine
2 Methylglyoxal
2 Pachymic acid
2 Phenethyl isothiocyanate
2 Thymoquinone
2 Vitamin B5,Pantothenic Acid
2 Vitamin K2
1 Sorafenib (brand name Nexavar)
1 cetuximab
1 Anthocyanins
1 Auranofin
1 Acetyl-l-carnitine
1 Andrographis
1 doxorubicin
1 Artemisinin
1 Aloe anthraquinones
1 Betulinic acid
1 Brutieridin–Melitidin Mixture
1 Boron
1 Boswellia (frankincense)
1 α-Bisabolol / Chamomile oil
1 Bullatacin
1 Carvacrol
1 Cannabidiol
1 Celecoxib
1 Centella asiatica / Gotu kola → asiaticoside
1 Chlorogenic acid
1 Cichoric acid / Chicoric acid
1 Chlorella (Chlorella vulgaris)
1 Spirulina(Arthrospira/Limnospira)
1 Dichloroacetate
1 Diindolylmethane
1 Disulfiram
1 Electrical Pulses
1 Ferulic acid
1 Ginseng
1 hydrogen sulfide
1 Hyperthermia
1 Isobavachalcone
1 Inositol
1 isoquercitrin
1 itraconazole
1 Lapachol
1 Lasiodin
1 Lycopene
1 MCT oil
1 Methyl Jasmonate
1 Magnetic Field Rotating
1 Magnesium
1 Moringa oleifera
1 Morin
1 Mushroom Chaga, Inonotus obliquus
1 Pterostilbene
1 Radio Frequency
1 EMF
1 SonoDynamic Therapy UltraSound
1 triptolide
1 Vitamin B1/Thiamine
1 Vitamin B12
1 Folic Acid, Vit B9
1 Vitamin B2,Riboflavin
1 Arsenic trioxide
1 probiotics
1 Vitexin
1 γ-Tocotrienol
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:21  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page